Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial. (Q48957285)
Jump to navigation
Jump to search
scientific article published on 9 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial. |
scientific article published on 9 November 2009 |
Statements
1 reference
Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial. (English)
1 reference
M Lebwohl
1 reference
C Han
1 reference
B Schenkel
1 reference
N Yeilding
1 reference
Y Wang
1 reference
G G Krueger
1 reference
9 November 2009
1 reference
162
1 reference
1
1 reference
137-146
1 reference